| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/07/2005 | US20050147604 Means and methods for diagnosing and treating affective disorders |
| 07/07/2005 | US20050147603 Employing nonimmunogenic blood products from patients with autoimmune disease |
| 07/07/2005 | US20050147593 Targeting cells expressing low molecular weight protein tyrosine kinase (LMW-PTP) utilizing nucleic acid operatively associated with delivery vehicle |
| 07/07/2005 | US20050147586 Novel therapeutic processes and useful compositions therefor |
| 07/07/2005 | US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 07/07/2005 | DE20023659U1 Molekulare Marker zum Testen der phänotypischen Stabilität von Zellpopulationen und Zellpopulationen für die autologe Transplantation Molecular markers for testing the phenotypic stability of cell populations and populations of cells for autologous transplantation |
| 07/07/2005 | CA2688944A1 Humanized anti-ngf antibodies |
| 07/07/2005 | CA2551546A1 Preventive/remedy for cancer |
| 07/07/2005 | CA2551454A1 Antiviral preparations obtained from a natural cinnamon extract |
| 07/07/2005 | CA2551009A1 A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/07/2005 | CA2550592A1 Identification of antigenically important neisseria antigens by screening insertional mutant libraries with antiserum |
| 07/07/2005 | CA2550482A1 Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders |
| 07/07/2005 | CA2549937A1 Human anti-idiotypic antibody fragments that mimic her-2/neu |
| 07/07/2005 | CA2549306A1 Methods of modulating cytokine activity; related reagents |
| 07/07/2005 | CA2549237A1 Detection of cd20 in transplant rejection |
| 07/07/2005 | CA2549173A1 Modulation of immunostimulatory properties by small oligonucleotide-based compounds |
| 07/07/2005 | CA2549168A1 Method for improving body weight uniformity and increasing carcass yield in animals |
| 07/07/2005 | CA2549122A1 Detection of cd20 in therapy of autoimmune diseases |
| 07/07/2005 | CA2549114A1 Immunostimulant composition comprising at least one toll-like 7 receptor or toll-like 8 receptor agonist and a toll-like 4 receptor agonist |
| 07/07/2005 | CA2548452A1 Medicament comprising inhibitors of long pentraxin ptx3 |
| 07/07/2005 | CA2548065A1 Anti-igf-i receptor antibody |
| 07/07/2005 | CA2544562A1 Bispecific antibodies |
| 07/07/2005 | CA2529694A1 Humanized anti-ccr2 antibodies and methods of use therefor |
| 07/07/2005 | CA2522421A1 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein |
| 07/06/2005 | EP1550729A1 Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain |
| 07/06/2005 | EP1550459A1 Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 07/06/2005 | EP1550458A1 Synergistic liposomal adjuvants |
| 07/06/2005 | EP1550457A1 Vaccine composition comprising interleukin-15 (il-15) |
| 07/06/2005 | EP1550454A1 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/06/2005 | EP1550449A1 Antitumor agents with the use of hsv |
| 07/06/2005 | EP1549763A2 Prophylactic and therapeutic hiv aptamers |
| 07/06/2005 | EP1549760A2 Sak: modulation of cellular proliferation for treatment of cancer |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549750A1 Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses thereof |
| 07/06/2005 | EP1549676A1 Genes and polypeptides relating to human myeloid leukemia |
| 07/06/2005 | EP1549673A2 Novel mhc ii associated peptides |
| 07/06/2005 | EP1549353A2 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 07/06/2005 | EP1549351A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/06/2005 | EP1549346A2 Amended recombinant cells (arcs) for the production and delivery of antiviral agents, adjuvants and vaccine accelerants |
| 07/06/2005 | EP1549345A1 Bispecific anti-erb-b antibodies and their use in tumor therapy |
| 07/06/2005 | EP1549344A1 Pharmaceutical compositions directed to erb-b1 receptors |
| 07/06/2005 | EP1549343A2 Method for the treatment of nephritis using anti-pdgf-dd antibodies |
| 07/06/2005 | EP1549342A2 Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
| 07/06/2005 | EP1549341A2 Novel tissue factor targeted antibodies as anticoagulants |
| 07/06/2005 | EP1549340A1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 07/06/2005 | EP1549339A2 Targeting of herpes simplex virus to specific receptors |
| 07/06/2005 | EP1549338A1 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| 07/06/2005 | EP1549335A1 A method of modulating cellular activity and molecules for use therein |
| 07/06/2005 | EP1549322A2 Lipid a and other carbohydrate ligand analogs |
| 07/06/2005 | EP1549290A1 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 07/06/2005 | EP1549277A1 Induction and maintenance of tolerance to composite tissue allografts |
| 07/06/2005 | EP1549198A2 Thymic atrophy |
| 07/06/2005 | EP1549140A2 Production of peptides in plants as viral coat protein fusions |
| 07/06/2005 | EP1549135A2 Vaccine compositions and adjuvant |
| 07/06/2005 | EP1222280B1 Apoptosis inducing proteinaceous substance |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636063A Genetic vaccine against human immunodeficiency virus |
| 07/06/2005 | CN1636060A Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 07/06/2005 | CN1636050A Core-glycosylated HCV envelope proteins |
| 07/06/2005 | CN1636018A 组织特异性表达 Tissue-specific expression |
| 07/06/2005 | CN1636017A Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 07/06/2005 | CN1636015A HCV e1e2 vaccine compositions |
| 07/06/2005 | CN1636013A DNA vaccines encoding HIV accessory proteins |
| 07/06/2005 | CN1636012A Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 07/06/2005 | CN1635988A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/06/2005 | CN1635910A Treatment and diagnosis of macrophage mediated disease |
| 07/06/2005 | CN1635908A Antibodies that immunospecifically bind to trail receptors |
| 07/06/2005 | CN1635906A Method of preventing cell death using antibodies to neural thread proteins |
| 07/06/2005 | CN1635905A Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 07/06/2005 | CN1635904A 肺炎链球菌疫苗 Streptococcus pneumoniae vaccine |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1635896A Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease |
| 07/06/2005 | CN1635876A 人免疫缺陷病毒疫苗 Human immunodeficiency virus vaccine |
| 07/06/2005 | CN1634994A Antineoplastic rat light chain single domain antibody - Cefuroxime Sodium reinforced fusion protein VL-LDP-AE |
| 07/06/2005 | CN1634991A Human anti-tetanotoxin monoclonal antibody, method for preparation and application |
| 07/06/2005 | CN1634989A Bacillus coli resisting chicken yolk antibody, its preparation and use |
| 07/06/2005 | CN1634978A SARS virus HLA-A2 limited epitope polypeptide and uses thereof |
| 07/06/2005 | CN1634596A Gene engineering vaccine used for preventing pig cysticercosis and its preparation method |
| 07/06/2005 | CN1634582A Crosslinker of anti-FcªŠRIª‡ monoclonal antibody Fab and tripterine |
| 07/06/2005 | CN1634581A Vaccine composition for preventing AIDS |
| 07/06/2005 | CN1634580A Split encephalitis B virus vaccine and method for preparing the same |
| 07/06/2005 | CN1634579A Inactivated BCG vaccine spray and method for preparing the same |
| 07/06/2005 | CN1634578A Leptospirosis vaccine and its use |
| 07/05/2005 | US6914134 Feline calicivirus genes and vaccines in particular recombinant vaccines |
| 07/05/2005 | US6913907 Enterococcus faecalis polynucleotides encoding EF059 |
| 07/05/2005 | US6913892 Method of obtaining compositions comprising Y4 specific compounds |
| 07/05/2005 | US6913767 For aids |
| 07/05/2005 | US6913757 Live, avirulent strain of V. anguillarum that protects fish against infection by virulent V. anguillarum and method of making the same |
| 07/05/2005 | US6913755 Amino acid substituted DNA sequences for use as vaccines against streptococcus |
| 07/05/2005 | US6913754 Renibacterium salmoninarum vaccine |
| 07/05/2005 | US6913753 Incapacitated whole-cell immunogenic bacterial compositions |
| 07/05/2005 | US6913752 Characterized by the loss of its capability to reproductively replicate in human cell lines. |
| 07/05/2005 | US6913751 Recombinant avian herpesvirus useful in vaccine production |
| 07/05/2005 | US6913750 Therapeutic compounds structurally-linked to bacterial polypeptides |
| 07/05/2005 | US6913749 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies |
| 07/05/2005 | US6913748 Cross-linkers with high reactivity and solubility and their use in the preparation of conjugates for targeted delivery of small molecule drugs |
| 07/05/2005 | US6913747 Humanized immunoglobulin reactive with B7 therewith |
| 07/05/2005 | US6913746 The polysaccharides in the complexes form an envelope which protects and carries immunoglobulins allowing their systemic absorption through gastric and mucosal membrane; polysacchride and immunoglobulins are bonded by ionic bonds |
| 07/05/2005 | US6913745 Passive immunization of Alzheimer's disease |